| NCT Number | NCT06419816 |
| Lead Sponsor | Daewoong Pharmaceutical Co. LTD. |
| Conditions | Type 2 Diabetes |
| Enrollment | 471 participants |
| Start Date | 2024-06-11 |
| Primary Completion | 2025-12-31 (estimated) |
| Study Completion | 2026-06-30 (estimated) |
| Updated on ClinicalTrials.gov | 2025-09-02 |